CTG stands for Cardiotocography, a medical procedure used to monitor the fetal heart rate (FHR) and uterine contractions during pregnancy and labor. It is a non-invasive technique that includes two components – electronic fetal monitoring (EFM) and uterine activity monitoring.
During CTG, two sensors are placed on the mother's abdomen. One sensor records the fetal heart rate by detecting the electrical impulses of the baby's heart, while the other sensor measures the uterine contractions by sensing the changes in the abdominal pressure. The information collected by these sensors is displayed on a monitor or printed on a paper strip known as a CTG trace.
The CTG trace provides valuable information about the well-being of the fetus, including its heart rate patterns and how it responds to contractions. It enables healthcare professionals, such as obstetricians or midwives, to assess the baby's health and detect any signs of distress or abnormalities. Consequently, CTG is a crucial tool in monitoring and ensuring the safety of both the mother and the baby during pregnancy and labor.
By analyzing the variations and accelerations in the fetal heart rate and monitoring the frequency, duration, and intensity of uterine contractions, CTG can help identify potential complications or issues that might require medical intervention. It is commonly performed in cases of high-risk pregnancies, prolonged labor, or if the healthcare provider suspects fetal distress or insufficient oxygen supply to the baby.
Overall, CTG plays a vital role in the assessment and management of fetal well-being, providing important insights that aid healthcare professionals in making informed decisions regarding the mother and baby's care and ensuring the best possible outcomes for both.
